Agilent Technologies, Inc. $A Shares Bought by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. grew its position in shares of Agilent Technologies, Inc. (NYSE:A) by 3.8% in the third quarter, Holdings Channel reports. The institutional investor owned 607,914 shares of the medical research company’s stock after buying an additional 22,498 shares during the period. Envestnet Asset Management Inc.’s holdings in Agilent Technologies were worth $78,026,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the company. Norges Bank purchased a new position in Agilent Technologies during the second quarter worth about $395,088,000. AQR Capital Management LLC increased its position in Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. raised its stake in shares of Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after buying an additional 1,340,161 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after buying an additional 1,273,994 shares in the last quarter. Finally, Troy Asset Management Ltd lifted its holdings in shares of Agilent Technologies by 74.3% in the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after buying an additional 1,021,865 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on A shares. The Goldman Sachs Group started coverage on Agilent Technologies in a report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective on the stock. Morgan Stanley started coverage on shares of Agilent Technologies in a research note on Tuesday, December 2nd. They set an “overweight” rating on the stock. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target for the company. JPMorgan Chase & Co. boosted their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Robert W. Baird boosted their price target on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $164.50.

Agilent Technologies Stock Up 0.1%

A stock opened at $129.76 on Monday. The company’s 50 day simple moving average is $139.96 and its 200-day simple moving average is $135.26. The firm has a market capitalization of $36.79 billion, a PE ratio of 28.39, a P/E/G ratio of 3.76 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same period in the previous year, the firm posted $1.46 EPS. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, January 6th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is 22.32%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the sale, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This trade represents a 2.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 16,401 shares of company stock valued at $2,468,962. 0.26% of the stock is currently owned by company insiders.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.